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Purpose/Objective: Lung cancer patients experience changes of the 
lung tissue density due to atelectasis, pleural effusion or 
pneumonia/pneumonitis. Changes may be an indication for adaptation 
of the treatment plan in order to preserve sufficient target coverage. 
This study investigates when and for how many patients adaptation is 
needed due to these kinds of changes. 
Materials and Methods: We have analysed 165 lung cancer patients 
(Small Cell and Non-Small Cell) with daily cone-beam CT (CBCT). The 
CBCT scans were reviewed to find all patients with atelectasis, pleural 
effusion, pneumonia/ pneumonitis. For all patients we looked for the 
fraction number, when the change appeared and disappeared, the 
measurable size of the change and the consequences for the dose 
distribution. In addition it was estimated if the lung change gave rise 
to a shift of the tumour leading to a geometric miss. 
Results: 43 patients (26%) of the 165 lung cancer patients investigated 
had changes in their lung. 24 (15%) experienced atelectasis, 19 (12% ) 
pleura effusion and 8 (5%) had pneumonia/pneumonitis visible on 
CBCT. Only major density changes had consequences for the dose 
distribution, and we found that 7 % need an adaptive treatment plan, 
when we accept 1% change in the mean dose to PTV (Planning target 
volume) and under dosage of 3% of the PTV.  
In 42% of the atelectasis cases (6% of all patients) an appearing or 
disappearing atelectasis introduced a shift of the tumour larger than 5 
mm and hence a risk of geometric miss with consequences for the 
dose distribution.  
With respect to time of appearance and disappearance there is no 
system for pneumonia/pneumonitis and pleural effusion. For the 
atelectasis the time of appearance and disappearance is shown in fig. 
1. Half of the atelectasis cases are present at CT, while the other half 
appears during treatment. Only three patients have an atelectasis at 
CT that does not disappear at some point during the treatment. 
 
 
Fig. 1: Appearance and disappearance of atelectasis in 24patients. For 
each patient the grey bar shows the time interval with atelectasis 
present. Fraction 0 represents the planning CT-scan. 
Conclusions: For the 165 patients reviewed on CBCT an adaptive plan 
is necessary to assure a correct target coverage either due to changes 
in lung density in 12 patients (7%) or due to shift of the tumour 
because of the anatomical changes in 10 patients (6%). In total this 
corresponds to 12 % of the patients being candidates for an adaptive 
treatment plan as a few patients are present in both groups. We do 
not find a clear system in the time of appearance nor disappearance 
of the changes,and we therefore recommend that an adaptive 
strategy is based on population based criteria, but evaluated on the 
individual patient by the RTT on a daily basis.  
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Purpose/Objective: Differential motion between the tumor, involved 
lymph nodes and surrounding anatomy is frequently observed in 
locally advanced lung cancer patients treated with radiotherapy (RT). 
Perfect alignment can then not be achieved with an image guided 
couch correction but adaptive radiotherapy has the potential to 
improve the accuracy. Rather than making a new planning CT 
(possibly introducing new systematic errors) we propose to generate a 
CT scan on which the new plan can be made, based on the average 
anatomy of the patient as captured in the Cone Beam CTs (CBCTs) 
made over multiple fractions. 
Materials and Methods: A group of 25 patients was selected with 
locally advanced lung cancer treated with radical RT. These patients 
had a gold marker implanted in a mediastinal lymph node prior to 
making the planning CT scan. Using a rigid registration of the carina, 
tumor and the implanted marker we determined the relative shift of 
lymph node and tumor with respect to the carina. An automated 
decision rule was used to determine which patients had a systematic 
baseline shift of the tumor with respect to the carina large enough 
that a new planning could be beneficial, and at which fraction the 
replanning process should be started. Five patients were thus 
selected. 
For these patients the planning CT scan was deformably registered 
(multi resolution b-spline model combined with a smoothness penalty 
term) to the CBCTs made during the previous 6 fractions. The inverse 
average deformation field was applied to the original planning CT to 
obtain the average patient model. 
To validate this model, the generated CT scan was rigidly registered 
to the underlying CBCTs. If the generated CT is a good model of the 
patient anatomy, these rigid registrations should reduce the 
systematic baseline shift of the tumor and lymph nodes with respect 
to the carina. 
Results: The figure shows the planning CT scan (a) of one patient with 
delineated tumor, the CBCT (b) where the baseline shift of the tumor 
is apparent, and the generated CT (c) which accommodates the 
baseline shift. 
Table 1 shows in the first column of each patient the average baseline 
shift (in all three directions combined) over 6 fractions as seen in the 
CBCTs relative to the planning CT for both tumor and lymph node 
marker. The second column of each patient shows the average 
baseline shift with respect to generated average CT. This table shows 
a reduction in systematicbaseline shift for the tumor for all patients. 
The lymph node positions are less well modeled, as they are hidden 
inside the mediastinum. 
 
 
  
Conclusions: The average patient model based on deformable 
registration of the planning CT to CBCTs acquired prior to treatment is 
capable of reducing the systematic baseline shift of the tumor with 
respect to the carina. Further improvement in the deformable 
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registration algorithm underlying the average patient model might 
further reduce these baseline shifts, and enhance performance within 
the mediastinum. 
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Purpose/Objective: To provide a framework for selecting CTV-PTV 
margins in SBRT for achieving institution-specific requirements on 
target coverage. 
Materials and Methods: The Van Herk et al. (VH) formalism, providing 
margin components for systematic and random errors, was extended 
to allow selection of margins for SBRT. VH accounts for systematic 
errors, requesting that 90% of treated patients should have 100% of 
the CTV covered by at least 95% of the prescribed dose, providing the 
well-known margin component 2.5 ∑. We generalized this model to 
allow selection of margins for nearly (95-100%) full CTV coverage for a 
high percentage (90-98%) of treated patients. For random errors, a 
model based on VH was fitted using clinical dose distributions to 
account for typical SBRT prescription levels (67% and 80%), and the 
variety in dose gradients resulting from multiple beams. As a result, 
we propose margins to be selected according to: 
 where ∑eff and σeff represent effective standard deviations of the 
systematic and total random errors (consisting of intra and inter-
fraction random errors), respectively. A look-up graph is provided for 
α, requiring the radius (Reff) of a sphere with a volume equal to the 
clinical CTV.  
Monte Carlo simulations were used to test the overall performance of 
the framework using 25 liver SBRT treatment plans at 67% and 80% 
prescription dose levels, simulating clinically representative target 
displacements. To this end, artificial PTVs (conforming to the 
prescription iso-dose) were generated to verify the performance of 
the framework for perfectly conformal plans. Clinical PTVs were used 
to test the framework for not perfectly conformal plans, having parts 
of the PTV under-dosed. 
Results: Values for α strongly depend on the requested population 
coverage and CTV volume coverage (Vpres), see figure. For an almost 
full CTV coverage (>99%) and high population coverage (98%) with 
clinically representative displacements (∑ = 2 mm) and tumor sizes 
(Reff = 2 cm) a values are close to the 2.5 of the VH-recipe. Typically, 
margins of 7 mm are found for clinically representative systematic and 
random errors.  
For 98% of the simulated treatments with perfectly conformal plans at 
both prescription levels, the CTV coverage was between 99 and 100%, 
satisfying the selected requirements. The CTV coverage dropped 
below 99% when PTV coverage was compromised more than 2% in non-
conformal plans. Treated volume outside the PTV could not 
compensate for under-dosing other parts of the PTV.  
 Conclusions: A framework was developed to select CTV-PTV margins 
that realize institution-specific requirements for a pre-defined (high) 
percentage of patients and a pre-defined (almost full) CTV coverage. 
Margins can be determined from a simple formula and a look up 
graph. The recipe was demonstrated to obtain the expected CTV 
coverage in simulations of 25 SBRT liver treatments. 
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Purpose/Objective: Adaptive radiotherapy (ART) of bladder cancer 
often involves daily selection from a library of treatment plans. The 
plans may be derived from Boolean operations on the geometrical 
configurations of the bladder as seen in CBCTs acquired during the 
first days of treatment. The resulting plans are highly dependent on 
the bladder shapes in this limited sample of bladder geometries. The 
aim of this study was to investigate whether use of deformation 
vector fields derived from registration of these initial CBCTs to the 
planning CT results in more conformal plan libraries, evaluated on the 
basis of the treated volume across the treatment course. 
Materials and Methods: A series of bladder cancer patients originally 
treated using non-adaptive RT (with anisotropic margins of up to 2cm) 
were re-planned with two alternative ART strategies. The first 
strategy considered has recently been introduced clinically in our 
institution, and is a contour-based adaptive scheme based on the 
union of the bladder volumes from CBCT-scans of first week of 
treatment (Clinical ART). The 2nd strategy was based on deformation 
vector fields (DVFs) from deformable image registrations between the 
planning CT and each of the CBCTs from the first week of treatment 
(DVF-based ART). In the DVF-based approach the library plans were 
created using combinations of the overall mean DVF (mDVF) and its 
standard deviation (sdDVF). In all plans for both strategies, a 5 mm 
isotropic margin for intra-fractional bladder motion was used. The 
treatment course averaged volume of the selected target volumes was 
calculated for each patient using each of the ART strategies. The 
volume ratios relative to the non-adaptive treatment for the two 
strategies were compared using a Wilcoxon signed rank test. 
Normality of the distribution of DVFs was validated on voxel level by 
using the Shapiro-Wilk test. The study was based on five patients with 
a total of 146 daily CBCT scans. 
Results: The median and range of the volume ratio, compared to non-
adaptive RT (PTVART/ PTVnon-ART) was 0.60 [0.48-0.65] for DVF-based 
ART, compared to 0.71 [0.63-0.79] for our current clinical ART 
strategy (p=0.04). The number of fractions where the bladder was not 
completely covered with the large size plan was 5% and 10% for the 
clinical ART and DVF-based strategy, respectively. The Shapiro-Wilk 
test showed normally distributed deformation vectors over on average 
76% of the entire DVFs. 
  
Figure 1: The volume ratio PTVART/ PTVnon-ART over the entire 
treatment course of each patient is shown for the clinical treatment 
strategy as well as the DVF-based strategy. 
 
Conclusions: The use of DVFs from deformable registrations for 
creation of ART plan libraries is feasible and leads to an additional, 
statistically significant improvement in normal tissue sparing 
compared to an already highly conformal, clinically applied ART 
strategy.  
   
 
